Review: Mechanistic and clinical overview of cardiovascular toxicity with BRAF and MEK inhibitors.
17 Mar, 2022 | 08:34h | UTC
Commentary on Twitter
New #JACCCardioOnc issue is out!
BRAF/MEK inhibitors are associated w/ adverse CV effects including HTN, LV dysfunction, #VTE, atrial arrhythmias, & QT prolongation. Learn more in this state-of-the-art review: https://t.co/2r9L90DTmL#CardioOnc #CardioTwitter #Hypertension pic.twitter.com/Dz8i0sfBTU
— JACC Journals (@JACCJournals) March 15, 2022